CASTLE BIOSCIENCES, INC. Investing Cash Flow
CASTLE BIOSCIENCES, INC. (CSTL) reported Investing Cash Flow of -$41.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$15.96M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$25.80M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $8.83M, a 53.05% increase year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$18.39M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$60.37M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$50.14M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$16.18M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$166.54M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$41.77M 10-Q · filed 2026-07-30 | -$32.94M derived: sum of 3 quarters · filed 2026-07-30 | -$51.32M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$25.80M 10-Q · filed 2026-05-06 | -$16.97M derived: sum of 2 quarters · filed 2026-05-06 | -$35.36M derived: sum of 3 quarters · filed 2026-05-06 | -$63.74M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.56M derived: sum of 2 quarters · filed 2026-02-26 | -$37.94M derived: sum of 3 quarters · filed 2026-07-30 | -$60.37M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$18.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$46.77M derived: sum of 2 quarters · filed 2026-07-30 | -$69.20M 10-Q · filed 2025-11-03 | -$63.43M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | -$28.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$50.81M 10-Q · filed 2026-07-30 | -$45.04M derived: sum of 3 quarters · filed 2026-07-30 | -$59.83M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$22.43M 10-Q · filed 2026-05-06 | -$16.66M derived: sum of 2 quarters · filed 2026-05-06 | -$31.45M derived: sum of 3 quarters · filed 2026-05-06 | -$52.87M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.02M derived: sum of 2 quarters · filed 2026-02-26 | -$30.44M derived: sum of 3 quarters · filed 2026-02-26 | -$50.14M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$14.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$36.21M derived: sum of 2 quarters · filed 2025-11-03 | -$55.91M 10-Q · filed 2025-11-03 | -$63.58M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$21.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$41.12M 10-Q · filed 2025-08-04 | -$48.79M derived: sum of 3 quarters · filed 2026-02-26 | -$58.50M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$19.70M 10-Q · filed 2025-05-05 | -$27.37M derived: sum of 2 quarters · filed 2026-02-26 | -$37.08M derived: sum of 3 quarters · filed 2026-02-26 | -$52.47M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$17.38M derived: sum of 2 quarters · filed 2026-02-26 | -$32.77M derived: sum of 3 quarters · filed 2026-02-26 | -$16.18M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$9.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$25.09M derived: sum of 2 quarters · filed 2024-11-04 | -$8.51M 10-Q · filed 2024-11-04 | -$12.99M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$15.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.20M 10-Q · filed 2024-08-05 | -$3.29M derived: sum of 3 quarters · filed 2025-02-27 | -$137.44M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $16.58M 10-Q · filed 2024-05-02 | $12.10M derived: sum of 2 quarters · filed 2025-02-27 | -$122.05M derived: sum of 3 quarters · filed 2025-02-27 | -$149.56M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$138.63M derived: sum of 2 quarters · filed 2025-02-27 | -$166.14M derived: sum of 3 quarters · filed 2025-02-27 | -$166.54M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$134.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$161.66M derived: sum of 2 quarters · filed 2023-11-02 | -$162.06M 10-Q · filed 2023-11-02 | -$192.95M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | -$27.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$27.91M 10-Q · filed 2023-08-02 | -$58.80M derived: sum of 3 quarters · filed 2023-08-02 | -$59.73M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | -$402.00K 10-Q · filed 2023-05-03 | -$31.29M derived: sum of 2 quarters · filed 2023-05-03 | -$32.21M derived: sum of 3 quarters · filed 2023-05-03 | -$66.31M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | -$30.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$31.81M derived: sum of 2 quarters · filed 2023-02-28 | -$65.91M derived: sum of 3 quarters · filed 2023-02-28 | -$66.66M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | -$923.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$35.02M derived: sum of 2 quarters · filed 2022-11-02 | -$35.77M 10-Q · filed 2022-11-02 | -$36.36M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | -$34.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$34.84M 10-Q · filed 2022-08-08 | -$35.43M derived: sum of 3 quarters · filed 2022-08-08 | -$37.34M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$750.00K 10-Q · filed 2022-05-09 | -$1.34M derived: sum of 2 quarters · filed 2022-05-09 | -$3.24M derived: sum of 3 quarters · filed 2022-05-09 | -$5.00M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.49M derived: sum of 2 quarters · filed 2022-02-28 | -$4.25M derived: sum of 3 quarters · filed 2022-02-28 | -$4.75M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$3.66M derived: sum of 2 quarters · filed 2021-11-08 | -$4.16M 10-Q · filed 2021-11-08 | -$4.51M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.26M 10-Q · filed 2021-08-09 | -$2.60M derived: sum of 3 quarters · filed 2021-08-09 | -$2.77M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | -$500.00K 10-Q · filed 2021-05-10 | -$847.00K derived: sum of 2 quarters · filed 2021-05-10 | -$1.01M derived: sum of 3 quarters · filed 2021-05-10 | -$1.19M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$513.00K derived: sum of 2 quarters · filed 2021-03-11 | -$693.00K derived: sum of 3 quarters · filed 2021-03-11 | -$937.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$346.00K derived: sum of 2 quarters · filed 2020-11-09 | -$590.00K 10-Q · filed 2020-11-09 | -$589.66K 10-Q · filed 2019-11-12 | -$595.38K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$424.00K 10-Q · filed 2020-08-10 | -$424.47K 10-Q · filed 2019-09-03 | -$429.38K derived: sum of 3 quarters · filed 2020-08-10 | -$516.39K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$244.00K 10-Q · filed 2020-05-11 | -$249.38K derived: sum of 2 quarters · filed 2020-05-11 | -$336.39K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$5.38K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$92.39K derived: sum of 2 quarters · filed 2020-03-10 | -$277.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | -$87.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$271.62K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$184.61K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |